Filing Details
- Accession Number:
- 0001127602-19-009119
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-01 11:42:12
- Reporting Period:
- 2019-02-27
- Accepted Time:
- 2019-03-01 11:42:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1650274 | Ross David Smith | 251 Ballardvale Street Wilmington MA 01887 | Corporate Executive Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-02-27 | 2,158 | $76.67 | 20,573 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.04 | 20,473 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.28 | 20,373 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.33 | 20,273 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.35 | 20,173 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.50 | 20,073 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.52 | 19,973 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.54 | 19,873 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.71 | 19,773 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.73 | 19,673 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 90 | $140.80 | 19,583 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 110 | $140.90 | 19,473 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $140.98 | 19,373 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $141.16 | 19,273 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $141.41 | 19,173 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $141.54 | 19,073 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $141.58 | 18,973 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $141.77 | 18,873 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $141.91 | 18,773 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $141.92 | 18,673 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 100 | $141.95 | 18,573 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-02-27 | 158 | $142.04 | 18,415 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2019-02-27 | 2,158 | $0.00 | 2,158 | $76.67 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-02-27 | 2020-02-27 | No | 4 | M | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.